Automate 90% of Intake Workflows with AI
Discover how AI-powered automation can streamline post-acute care workflows, freeing staff to focus on patient care and reducing administrative burdens.
Executive Brief
- The News: Alita's AI agent automates 90% of post-acute care workflows.
- Clinical Win: 75% of senior living prospects choose the first community that replies.
- Target Specialty: Post-acute care providers, especially nursing homes with staffing shortages.
Key Data at a Glance
Automation Coverage: 90% of busy work in client and resident intake and caregiver candidate screening
Response Time Advantage: 24/7 vs 24-48 hours
Senior Living Prospect Conversion: 75% choose the first community that replies
Average RN Vacancy Duration: 87 days
Language Support: over 100 languages
Setup Time: a few minutes
Automate 90% of Intake Workflows with AI
What You Should Know:
– Alita, a new AI agent purpose-built for post-acute care, has officially launched to help providers turn more conversations into care outcomes automatically, 24/7.
– The AI-powered agent brings empathetic automation to intake, hiring, and admissions workflows. It is designed to handle 90% of the busy work in client and resident intake and caregiver candidate screening, freeing up staff to focus on people, not paperwork.
A Broken System and the Cost of Inaction
The post-acute care industry faces mounting pressures from rising demand and shrinking staff. A significant challenge is that most leads for senior living and care come in after hours when no one is available to respond. The data tells a painful story: 75% of senior living prospects choose the first community that replies, yet most providers take 24-48 hours to follow up. This can lead to lost leads, and staff can become overrun.
Furthermore, nearly half of nursing homes are limiting admissions, with 57% reporting waitlists and 20% closing units due to staffing shortages. The average RN vacancy lasts 87 days, which fuels burnout and turnover. Matt Rosa, Alita’s Co-Founder and CEO, stated that this feeling of being ignored in a moment of urgency is what drove him to create Alita.
Alita’s Solution: Speed, Empathy, and Results
Alita’s AI-powered virtual agents are specifically trained for the post-acute and home care space. These agents engage families and job seekers 24/7, qualify them in real-time, and instantly book candidate interviews, facility tours, or care consultations.
The platform doesn’t just respond quickly; it automatically qualifies leads for fit, which means staff spends less time chasing unqualified leads. Setup is simple and takes just a few minutes, with limited or no IT involvement required. The AI agent is also trained for empathy and is fluent in over 100 languages.
Alita has already demonstrated impressive results, including:
Clinical Perspective — Dr. Simran Kohli, Infectious Diseases
Workflow: I'd say Alita's AI agent is a game-changer for post-acute care workflows, handling 90% of the busy work in client and resident intake and caregiver candidate screening. This means I can focus on high-touch tasks, not paperwork. With Alita, I can ensure timely follow-ups, as 75% of senior living prospects choose the first community that replies.
Economics: The article doesn't address cost directly, but I'm aware that staffing shortages and lost leads can be costly. For instance, the average RN vacancy lasts 87 days, which can fuel burnout and turnover, ultimately affecting our bottom line. Alita's potential to streamline workflows and reduce waitlists could have a significant economic impact.
Patient Outcomes: With Alita, I can provide more timely and empathetic care to my patients. The platform's ability to engage families and job seekers 24/7 and qualify them in real-time can lead to better care outcomes. For example, Alita can help reduce the time it takes to book care consultations, which can improve patient satisfaction and outcomes, especially considering that 57% of nursing homes are reporting waitlists.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact robert.foster@straventgroup.com.